logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
R

Ryan J. Brisson

University of California San Francisco
H指数:14
被引数:861

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

EQual Rubric Evaluation of the Radiation Oncology Education Collaborative Study Group Entrustable Professional Activities

放射肿瘤学教育协作研究小组可委托专业活动的等距评分量规评估

Journal of Cancer Education
IF1.3
2026-01-010
PRE
Wagner, Brett; Braunstein, Steve; Brisson, Ryan; De Leo, Alexandra; Garda, Allison; Gunther, Jillian; Henson, Christina; Hirsch, Ariel E.; Holmes, Jordan; Katz, Leah; Mattes, Malcolm; Schuster, Jessica Moore; Price, Jeremy; Shiue, Kevin; Thomas, Horatio; Golden, Daniel W.
EQual Rubric Evaluation of the Radiation Oncology Education Collaborative Study Group Entrustable Professional Activities

辐射肿瘤学教育协作研究小组可委托专业活动的等量评分量规评估

international journal of radiation oncology biology physics
IF0
2025-08-130
PRE
Brett Wagner; Steve Braunstein; Ryan Brisson; Alexandra De Leo; Allison Garda; Jillian Gunther; Christina Henson; Ariel E Hirsch; Jordan Holmes; Leah Katz; Malcolm Mattes; Jessica Moore Schuster; Jeremy Price; Kevin Shiue; Horatio Thomas; Daniel W. Golden
Immune-related adverse events are associated with improved response, progression-free survival, and overall survival for patients with head and neck cancer receiving immune checkpoint inhibitors

免疫相关不良事件与接受免疫检查点抑制剂的头颈癌患者的反应改善、无进展生存期和总生存期相关

CANCER
IF5.1
2021-09-2152
OAAI
Foster, Corey C.; Couey, Marcus A.; Kochanny, Sara E.; Khattri, Arun; Acharya, Rajesh K.; Tan, Yi-Hung Carol; Brisson, Ryan J.; Leidner, Rom S.; Seiwert, Tanguy Y.
A randomized phase 2 network trial of tivantinib plus cetuximab versus cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma

tivantinib联合西妥昔单抗与西妥昔单抗在复发/转移性头颈部鳞状细胞癌患者中的随机2期网络试验

CANCER
IF5.1
2020-02-1927
OAAI
Kochanny, Sara E.; Worden, Francis P.; Adkins, Douglas R.; Lim, Dean W.; Bauman, Julie E.; Wagner, Stephanie A.; Brisson, Ryan J.; Karrison, Theodore G.; Stadler, Walter M.; Vokes, Everett E.; Seiwert, Tanguy Y.
OPTIMAd-A Phase 2 Trial of Induction Chemotherapy Response-Stratified Radiation Therapy Dose and Volume De-escalation for HPV plus Oropharyngeal Cancer: Efficacy, Toxicity, and HPV Subtype Analysis
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
IF6.5
2018-04-012
PREAI
Seiwert, T.; Melotek, J. M.; Foster, C. C.; Blair, E. A.; Karrison, T. G.; Agrawal, N.; Portugal, L.; Gooi, Z.; Stenson, K. M.; Brisson, R. J.; Arshad, S.; Dekker, A.; Kochanny, S.; Saloura, V.; Spiotto, M. T.; Villaflor, V. M.; Haraf, D. J.; Vokes, E. E.

研究方向

暂未获取到该数据
T
Tanguy Y. Seiwert
H 指数:60论文数:405被引数:2.2万
E
Everett E. Vokes
H 指数:119论文数:1,236被引数:7.9万
D
Daniel J. Haraf
H 指数:55论文数:262被引数:1.0万
J
J.M. Melotek
H 指数:11论文数:74被引数:1,300
E
Elizabeth A. Blair
H 指数:39论文数:226被引数:5,345
V
Victoria Villaflor
H 指数:34论文数:243被引数:4,851
K
Kerstin Stenson
H 指数:42论文数:190被引数:6,809
T
Theodore Karrison
H 指数:79论文数:550被引数:2.3万
L
L. Portugal
H 指数:6论文数:37被引数:842
E
Ezra E.W. Cohen
H 指数:85论文数:867被引数:3.7万